TLPH

Talphera Inc

0.9037

+0.0254+2.89%

After Hours: 0.9037 0.0000 0.00%16:10 05/08 EDT

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE0.8710/0.8675

TODAY RANGE0.8338-0.8999

VOL124.24K

MARKET CAP44.50M

52 WEEK RANGE0.3800-1.570

AVG VOL (3M)187.72K

% TURNOVER0.24%

TURNOVER--

P/E (TTM)-2.5453

% RANGE7.62%

EPS(TTM)-0.3369

P/E(FORWARD)-2.4500

P/B2.483

BVPS0.3453

DIVIDEND--

P/S1,429.17

BETA--

DIV YIELD0.00%

FREE FLOAT MKT CAP30.80M

SHARES OUTSTANDING51.90M

NEXT EARNINGS05/12-05/18

FREE FLOAT35.92M

LOT SIZE1

EX-DATE10/26/2022

News

Press Releases

Financial Reports

Profile

Dow Jones·04/30 18:40
Talphera Price Target Announced at $3.00/Share by WestPark Capital
TipRanks·04/30 18:25
Talphera initiated with a Buy at WestPark Capital
Reuters·03/25 23:58
Talphera CEO Vincent J. Angotti acquires 213,310 common shares; value rises to $125,000
Reuters·03/25 12:31
Talphera announces two abstracts accepted for AKI & CRRT 2026; NEPHRO-CRRT nafamostat registrational study enrolls patients
PR Newswire·03/25 12:30
Talphera Announces Two Abstracts Accepted for Presentation at AKI & CRRT 2026
TipRanks·03/25 10:05
Talphera files to sell 639,931 shares of common stock for holders
TipRanks·03/24 13:10
Analysts Offer Insights on Healthcare Companies: Fennec Pharmaceuticals (FENC), Talphera (TLPH) and Abivax SA Sponsored ADR (ABVX)
TipRanks·03/24 11:40
Analysts Offer Insights on Healthcare Companies: Abivax SA Sponsored ADR (ABVX), Compass Therapeutics (CMPX) and Talphera (TLPH)
TipRanks·03/23 16:06
Midday Fly By: Musk to start Terafab project, Elliott takes stake in Synopsys
Seeking Alpha·03/23 13:16
Talphera GAAP EPS of -$0.06 beats by $0.01
TipRanks·03/23 12:41
Talphera reports Q4 EPS (6c) vs. (7c) last year
Reuters·03/23 12:39
Talphera Q4 net loss widens as operating expenses rise
Reuters·03/23 12:32
Talphera Q4 net loss widens 101.71% to USD 3.8 million on cash and investments of USD 20 million
Dow Jones·03/23 12:31
*Talphera 4Q Loss/Shr 6c Vs. Loss 7c >TLPH
Reuters·03/23 12:30
TALPHERA INC - EXPECTS 2026 CASH OPERATING EXPENSES EXCLUDING STOCK-BASED COMPENSATION OF $17 MLN-$18 MLN

Same Industry

Name/Symbol

Change%

Price

MCK

Biogen Inc

BIIB

+1.08%

193.45

AMGN

Shire

SHPG

0.00%

179.20

CELG-RT

Lilly Eli & Co

LLY

-2.72%

948.45

CELG

TXMD

JNJ

ABBV

ZTS

Gilead Sciences Inc

GILD

-2.04%

131.33

Novo-Nordisk A/S

NVO

+0.72%

46.40

BMY

Alexion Pharms

ALXN

+1.70%

182.50

Pfizer

PFE

-1.42%

25.68

Sanofi FR

SNY

+0.30%

43.31

GCVRZ

Novartis

NVS

+0.44%

146.03

Dr Reddys Labs

RDY

-1.49%

13.23

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.